Mortality rate patterns for hemorrhagic fever with renal syndrome caused by puumala virus

Emerging Infectious Diseases

Volumn 16, Issue 10, 2010, Pages 1584-1586

  Hjertqvist, Marika ^a   Klein, Sabra L ^b   Ahlm, Clas ^c   Klingström, Jona ^a,c,d  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UMEÅ UNIVERSITY   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FATALITY; FEMALE; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATHOGENESIS; PUUMALA VIRUS; SEX DIFFERENCE; SWEDEN;

ADULT; AGE FACTORS; AGED; FEMALE; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PUUMALA VIRUS; SEX FACTORS; SURVIVAL RATE; SWEDEN;

EID: 77958599053     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1610.100242     Document Type: Article

References (13)

1. Vapalahti O, Mustonen J, Lundkvist Å, Henttonen H, Plyusnin A, Vaheri A. Hantavirus infections in Europe. Lancet Infect Dis. 2003;3:653-61. DOI: 10.1016/S1473-3099(03)00774-6.
2. Schmaljohn C, Hjelle B. Hantaviruses: a global disease problem. Emerg Infect Dis. 1997;3:95-104. DOI: 10.3201/eid0302.970202.
3. Settergren B. Clinical aspects of nephropathia epidemica (Puumala virus infection) in Europe: a review. Scand J Infect Dis. 2000;32:125-32. DOI: 10.1080/003655400750045204.
4. Schönrich G, Rang A, Lütteke N, Raftery M, Charbonnel N, Ulrich R. Hantavirus-induced immunity in rodent reservoirs and humans. Immunol Rev. 2008;225:163-89. DOI: 10.1111/j.1600-065- X.2008.00694.x.
5. Klein SL. The effects of hormones on sex differences in infection: from genes to behavior. Neurosci Biobehav Rev. 2000;24:627-38. DOI: 10.1016/S0149-7634(00)00027-0.
6. Moore SL, Wilson K. Parasites as a viability cost of sexual selection in natural populations of mammals. Science. 2002;297:2015-8. DOI: 10.1126/science.1074196.
7. Fish EN. The X-fi les in immunity: sex based differences predispose immune responses. Nat Rev Immunol. 2008;8:737-44. DOI: 10.1038/nri2394.
8. Anker M. Addressing sex and gender in epidemic-prone infectious diseases. Geneva: World Health Organization Report; 2007.
9. Klein SL, Calisher CH. Emergence and persistence of hantaviruses. Curr Top Microbiol Immunol. 2007;315:217-52. DOI: 10.1007/978- 3-540-70962-6_10.
10. Ahlm C, Linderholm M, Juto P, Stegmyr B, Settergren B. Prevalence of serum IgG antibodies to Puumala virus (hemorrhagic fever with renal syndrome) in northern Sweden. Epidemiol Infect. 1994;113:129-36. DOI: 10.1017/S0950268800051542.
11. Klingström J, Lindgren T, Ahlm C. Sex-dependent differences in plasma cytokine responses to hantavirus infection. Clin Vaccine Immunol. 2008;15:885-7. DOI: 10.1128/CVI.00035-08.
12. Valtonen M, Kauppila M, Kotilainen P, Lähdevirta J, Svartbäck CM, Kosunen O, et al. Four fatal cases of nephropathia epidemica. Scand J Infect Dis. 1995;27:515-7. DOI: 10.3109/00365549509047057.
13. Thompson WW, Shay D, Weintraub E, Brammer L, Cox N, Anderson L, et al. Mortality associated with infl uenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179-86. DOI: 10.1001/jaa.289.2.179.